|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Research and development | |||||
| Sales and marketing | |||||
| General and administrative | |||||
| Amortization of intangibles | |||||
| Restructuring costs | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income, net | |||||
| Income from settlement of litigation | |||||
| Induced conversion expense | |||||
| Interest expense | |||||
| Income (loss) before income taxes | |||||
| Income tax benefit (expense) | |||||
| Net income (loss) | |||||
| Net income (loss) per share - basic | |||||
| Net income (loss) per share - diluted | |||||
| Weighted-average shares outstanding - basic | |||||
| Weighted-average shares outstanding - diluted | |||||
Loading...